149 related articles for article (PubMed ID: 15800866)
21. Synthesis of sulfonium sulfate analogues of disaccharides and their conversion to chain-extended homologues of salacinol: new glycosidase inhibitors.
Johnston BD; Jensen HH; Pinto BM
J Org Chem; 2006 Feb; 71(3):1111-8. PubMed ID: 16438529
[TBL] [Abstract][Full Text] [Related]
22. Synthesis of aza- and thia-spiroheterocycles and attempted synthesis of spiro sulfonium compounds related to salacinol.
Chen W; Pinto BM
Carbohydr Res; 2007 Nov; 342(15):2163-72. PubMed ID: 17669386
[TBL] [Abstract][Full Text] [Related]
23. Synthesis of polyhydroxylated piperidines and evaluation as glycosidase inhibitors.
Tite T; Lallemand MC; Poupon E; Kunesch N; Tillequin F; Gravier-Pelletier C; Le Merrer Y; Husson HP
Bioorg Med Chem; 2004 Oct; 12(19):5091-7. PubMed ID: 15351392
[TBL] [Abstract][Full Text] [Related]
24. Heterocyclic inhibitors of dihydrodipicolinate synthase are not competitive.
Turner JJ; Gerrard JA; Hutton CA
Bioorg Med Chem; 2005 Mar; 13(6):2133-40. PubMed ID: 15727866
[TBL] [Abstract][Full Text] [Related]
25. Functionalized pyrrolidine inhibitors of human type II alpha-mannosidases as anti-cancer agents: optimizing the fit to the active site.
Fiaux H; Kuntz DA; Hoffman D; Janzer RC; Gerber-Lemaire S; Rose DR; Juillerat-Jeanneret L
Bioorg Med Chem; 2008 Aug; 16(15):7337-46. PubMed ID: 18599296
[TBL] [Abstract][Full Text] [Related]
26. Multivalent inhibitors for carbohydrate-processing enzymes: beyond the "lock-and-key" concept.
Gouin SG
Chemistry; 2014 Sep; 20(37):11616-28. PubMed ID: 25081380
[TBL] [Abstract][Full Text] [Related]
27. Synthesis of N-benzyl substituted 1,4-imino-l-lyxitols with a basic functional group as selective inhibitors of Golgi α-mannosidase IIb.
Klunda T; Šesták S; Kóňa J; Poláková M
Bioorg Chem; 2019 Mar; 83():424-431. PubMed ID: 30428432
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and evaluation of thiazepines as interleukin-1beta converting enzyme (ICE) inhibitors.
Ellis CD; Oppong KA; Laufersweiler MC; O'Neil SV; Soper DL; Wang Y; Wos JA; Fancher AN; Lu W; Suchanek MK; Wang RL; De B; Demuth TP
Bioorg Med Chem Lett; 2006 Sep; 16(18):4728-32. PubMed ID: 16870441
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of anomeric 1,5-anhydrosugars as conformationally locked selective α-mannosidase inhibitors.
Mane RS; Ghosh S; Singh S; Chopade BA; Dhavale DD
Bioorg Med Chem; 2011 Nov; 19(22):6720-5. PubMed ID: 22001328
[TBL] [Abstract][Full Text] [Related]
30. Mechanism-based candidate inhibitors of uridine diphosphate galactopyranose mutase (UGM).
Mahdavi-Amiri Y; Mohan S; Borrelli S; Slowski K; Sanders DA; Pinto BM
Carbohydr Res; 2016 Jan; 419():1-7. PubMed ID: 26595659
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis, and biological evaluation of human sialidase inhibitors. Part 1: selective inhibitors of lysosomal sialidase (NEU1).
Magesh S; Moriya S; Suzuki T; Miyagi T; Ishida H; Kiso M
Bioorg Med Chem Lett; 2008 Jan; 18(2):532-7. PubMed ID: 18068975
[TBL] [Abstract][Full Text] [Related]
32. Synthesis of C-5-thioglycopyranosides and their sulfonium derivatives from 1-C-(2'-oxoalkyl)-5-S-acetylglycofuranosides.
Yi T; Wu SH; Zou W
Carbohydr Res; 2005 Feb; 340(2):235-44. PubMed ID: 15639243
[TBL] [Abstract][Full Text] [Related]
33. Straightforward one-pot synthesis of trifluoromethyl sulfonium salts.
Magnier E; Blazejewski JC; Tordeux M; Wakselman C
Angew Chem Int Ed Engl; 2006 Feb; 45(8):1279-82. PubMed ID: 16416481
[No Abstract] [Full Text] [Related]
34. 1,5-Alpha-D-mannoseptanosides, ring-size isomers that are impervious to alpha-mannosidase-catalyzed hydrolysis.
Boone MA; McDonald FE; Lichter J; Lutz S; Cao R; Hardcastle KI
Org Lett; 2009 Feb; 11(4):851-4. PubMed ID: 19154123
[TBL] [Abstract][Full Text] [Related]
35. Glycosyl sulfonium ions as storable intermediates for glycosylations.
Nokami T; Nozaki Y; Saigusa Y; Shibuya A; Manabe S; Ito Y; Yoshida J
Org Lett; 2011 Mar; 13(6):1544-7. PubMed ID: 21323371
[TBL] [Abstract][Full Text] [Related]
36. Synthesis of a novel class of sulfonium ions as potential inhibitors of UDP-galactopyranose mutase.
Ghavami A; Chen JJ; Mario Pinto B
Carbohydr Res; 2004 Jan; 339(2):401-7. PubMed ID: 14698899
[TBL] [Abstract][Full Text] [Related]
37. Virtual screening and QSAR study of some pyrrolidine derivatives as α-mannosidase inhibitors for binding feature analysis.
Moorthy NS; Brás NF; Ramos MJ; Fernandes PA
Bioorg Med Chem; 2012 Dec; 20(24):6945-59. PubMed ID: 23151473
[TBL] [Abstract][Full Text] [Related]
38. Design and synthesis of potent and selective azaindole-based Rho kinase (ROCK) inhibitors.
Schirok H; Kast R; Figueroa-Pérez S; Bennabi S; Gnoth MJ; Feurer A; Heckroth H; Thutewohl M; Paulsen H; Knorr A; Hütter J; Lobell M; Münter K; Geiss V; Ehmke H; Lang D; Radtke M; Mittendorf J; Stasch JP
ChemMedChem; 2008 Dec; 3(12):1893-904. PubMed ID: 18973168
[TBL] [Abstract][Full Text] [Related]
39. Mechanistic Insight into the Binding of Multivalent Pyrrolidines to α-Mannosidases.
Mirabella S; D'Adamio G; Matassini C; Goti A; Delgado S; Gimeno A; Robina I; Moreno-Vargas AJ; Šesták S; Jiménez-Barbero J; Cardona F
Chemistry; 2017 Oct; 23(58):14585-14596. PubMed ID: 28902965
[TBL] [Abstract][Full Text] [Related]
40. A combined STD-NMR/molecular modeling protocol for predicting the binding modes of the glycosidase inhibitors kifunensine and salacinol to Golgi alpha-mannosidase II.
Wen X; Yuan Y; Kuntz DA; Rose DR; Pinto BM
Biochemistry; 2005 May; 44(18):6729-37. PubMed ID: 15865418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
